Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers.
Sanjana BallalMadhav Prasad YadavEuy Sung MoonVasko S KramerFrank RoeschSamta KumariMadhavi TripathiSreedharan Thankarajan ArunRajSulochana SarswatChandrasekhar BalPublished in: European journal of nuclear medicine and molecular imaging (2020)
[68Ga]Ga-DOTA.SA.FAPi is a promising alternative among the FAPI class of molecules and performed well as compared to standard-of-care radiotracer [18F]F-FDG in the diagnosis of various cancers.